128 related articles for article (PubMed ID: 22626786)
1. Promoter methylation of esophageal cancer-related gene 4 in gastric cancer tissue and its clinical significance.
Wang YB; Ba CF
Hepatogastroenterology; 2012 Sep; 59(118):1696-8. PubMed ID: 22626786
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods.
Cheng ZD; Hu SL; Sun YB; Xu WP; Shen G; Kong XY
Chin J Cancer; 2010 Feb; 29(2):163-6. PubMed ID: 20109344
[TBL] [Abstract][Full Text] [Related]
3. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
[TBL] [Abstract][Full Text] [Related]
4. Downregulated ECRG4 is associated with poor prognosis in renal cell cancer and is regulated by promoter DNA methylation.
Luo L; Wu J; Xie J; Xia L; Qian X; Cai Z; Li Z
Tumour Biol; 2016 Jan; 37(1):1121-9. PubMed ID: 26276361
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between promoter methylation of Syk and Runx3 genes and postoperative recurrence and metastasis in gastric carcinoma].
Hong H; Zhou K; Fu P; Huang Q; Wang J; Yuan X; Li J
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):341-5. PubMed ID: 25030588
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation and expression of TIMP3 gene in gastric cancer.
Guan Z; Zhang J; Song S; Dai D
Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
[TBL] [Abstract][Full Text] [Related]
7. Expression of esophageal carcinoma related gene 4 (ECRG4) and its clinical significance in prognosis of esophageal carcinoma.
Wen Y; Hu X
Int J Clin Exp Pathol; 2015; 8(11):14772-8. PubMed ID: 26823803
[TBL] [Abstract][Full Text] [Related]
8. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.
Hiraki M; Kitajima Y; Sato S; Mitsuno M; Koga Y; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
Ann Surg Oncol; 2010 Apr; 17(4):1177-86. PubMed ID: 19957042
[TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer.
Zhang H; Song Y; Xia P; Cheng Y; Guo Q; Diao D; Wang W; Wu X; Liu D; Dang C
Med Oncol; 2014 Feb; 31(2):830. PubMed ID: 24381142
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
11. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
12. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
13. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
Chen X; Lin Z; Xue M; Si J; Chen S
PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
[TBL] [Abstract][Full Text] [Related]
14. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
[TBL] [Abstract][Full Text] [Related]
16. High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer.
Chen HY; Zhu BH; Zhang CH; Yang DJ; Peng JJ; Chen JH; Liu FK; He YL
Cancer Sci; 2012 Jan; 103(1):73-9. PubMed ID: 22017425
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
18. GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.
Eftang LL; Klajic J; Kristensen VN; Tost J; Esbensen QY; Blom GP; Bukholm IR; Bukholm G
BMC Cancer; 2016 Mar; 16():225. PubMed ID: 26984265
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer.
Tao K; Wu C; Wu K; Li W; Han G; Shuai X; Wang G
Med Oncol; 2012 Mar; 29(1):107-12. PubMed ID: 21264540
[TBL] [Abstract][Full Text] [Related]
20. Downregulation and DNA methylation of ECRG4 in gastric cancer.
Deng P; Chang XJ; Gao ZM; Xu XY; Sun AQ; Li K; Dai DQ
Onco Targets Ther; 2018; 11():4019-4028. PubMed ID: 30034241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
